| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 145.273 | 27.037 | 57.655 | 49.066 | 37.724 | 118.323 | 90.346 | 213.080 | 72.402 | 157.743 |
| Total Income - EUR | 145.758 | 46.772 | 60.668 | 49.966 | 60.423 | 118.323 | 90.346 | 213.717 | 72.402 | 164.828 |
| Total Expenses - EUR | 144.431 | 46.623 | 59.680 | 49.767 | 60.069 | 117.304 | 87.592 | 202.746 | 72.284 | 157.427 |
| Gross Profit/Loss - EUR | 1.327 | 149 | 989 | 199 | 354 | 1.019 | 2.755 | 10.971 | 118 | 7.401 |
| Net Profit/Loss - EUR | 1.327 | 149 | 589 | 119 | 297 | 864 | 2.251 | 9.251 | 37 | 6.300 |
| Employees | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Doping - Trans Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 28.880 | 40.082 | 31.920 | 21.076 | 34.921 | 28.752 | 28.660 | 2.852 | 1.930 | 3.604 |
| Current Assets | 61.076 | 6.953 | 26.101 | 27.160 | 26.753 | 55.206 | 27.619 | 75.577 | 41.158 | 50.161 |
| Inventories | 0 | 399 | 1.111 | 6.355 | 11.683 | 2.168 | 3.017 | 4.264 | 16.423 | 8.033 |
| Receivables | 60.476 | 1.031 | 24.245 | 19.704 | 5.567 | 51.901 | 13.446 | 58.522 | 13.005 | 36.006 |
| Cash | 599 | 5.524 | 745 | 1.100 | 9.504 | 1.137 | 11.156 | 12.791 | 11.730 | 6.122 |
| Shareholders Funds | 18.952 | 18.908 | 19.176 | 18.943 | 18.873 | 19.379 | 21.200 | 30.517 | 30.461 | 36.590 |
| Social Capital | 33.791 | 33.446 | 32.880 | 32.277 | 31.652 | 31.052 | 30.363 | 30.457 | 30.365 | 30.195 |
| Debts | 83.786 | 48.574 | 74.457 | 63.758 | 60.350 | 64.579 | 43.133 | 47.913 | 12.627 | 17.175 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Doping - Trans Srl